FindTrial
Sign In

Study on treatment of Post-Corona black fungus infection with Patient Customized Implants

Outcome assessment of Patient-Specific Implant in the rehabilitation of patients with Post-Covid Mucormycosis : A Prospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050380
Enrollment
10
Registered
2023-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B465- Mucormycosis, unspecified

Interventions

None listed

Sponsors

All India Institute of Medical Sciences, Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Patients with palatomaxillary defects and a history of covid-associated mucormycosis. - Patients rehabilitated by Patient-Specific Implants. - Giving positive informed consent.

Exclusion criteria

Exclusion criteria: - Presence of any residual disease

Design outcomes

Primary

MeasureTime frame
Evaluation of long term clinical implant stability, masticatory efficiency and estheticsTimepoint: at 6 Months, at 1 Year—

Secondary

MeasureTime frame
â?¢ To record the incidence of any post operative complications. â?¢ To corelate complications with extent of defect Timepoint: after 3 months of PSI placement—

Countries

India

Contacts

Public ContactSurabhi Somkuwar

All India Institute of Medical Sciences,Raipur

surabhi.somkuwar@gmail.com9425018985

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026